Alphatec Holdings Inc. (ATEC), a medical equipment and supplies holding company, saw its stock soar 6.69% in pre-market trading on Thursday. This surge came after the company reported robust financial results for the fourth quarter of 2024 and provided an optimistic outlook for 2025.
In the fourth quarter, Alphatec achieved total revenue of $177 million, a remarkable 28% year-over-year increase and 17% sequential growth. The company's surgical revenue grew by 28% year-over-year to $157 million, while its EOS revenue rose by 32% to $20 million. Alphatec also reported positive free cash flow of $9 million for the first time since its transformation.
Looking ahead, Alphatec provided an optimistic revenue outlook for 2025, projecting approximately $732 million in revenue, representing a 20% growth rate. The company also forecasted an adjusted EBITDA of $75 million for the upcoming year. These positive financial projections, coupled with the strong fourth-quarter performance, likely fueled investor confidence and drove the pre-market surge in Alphatec's stock price.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。